Examining the Psychedelic Renaissance
Season 2

A 15-week online event to explore, examine, and delve into the psychedelic Renaissance

Episode 10: Psychedelic-Assisted Psychotherapy for Eating Disorders and Cognitive Behavioural Therapies for PTSD + MDMA

November 24th, 5:00-6:30PM PST

Adele_LaFrance_Cropped

Dr. Adele Lafrance

Psychologist & Research Scientist –

Novamind

Dr. Reid Robison

Psychiatrist, Co-Founder – Cedar Psychiatry,

Medical Director

AnneWagner_cropped

Dr. Anne Wagner

Psychologist, Founder – REMEDY

Episode Summary: Hear from the MAPS Researchers. In this episode we will get to hear from some of the leading experts in the field of clinical psychedelic research. Both Dr. Adele Lafrance and Dr. Reid Robison are currently focussed on a study looking at using MDMA to treat PTSD. While Dr. Anne Wagner also has a background investigating Eating Disorders, she will be touching on her work with MDMA + Cognitive Processing Therapy.

Exclusive Post Webinar Sessions:    (Exclusive Post-Webinar Session Details:  Session take place in a private zoom room with the speaker and 6-10 other participants. Limited Capacity. Zoom links sent out the day of the event.  6:30-7:30PM PST, Tuesdays (following the speaker’s episode).  Webinar attendance is not mandatory; however all passes include 1 complimentary ticket to the entire series!  View all speaker post-webinar sessions here.)

  • Join Adele and Reid for an Exclusive Q&A. Reid is currently the coordinating investigator for the MAPS-sponsored study MDMA assisted psychotherapy study of eating disorders, and Adele is the clinical investigator and strategy lead for the MAPS-sponsored MDMA-assisted psychotherapy study for eating disorders. This is your chance to meet with the two of them and have all of your questions answered in a semi-private session. To register, see Ep 10Ex: Exclusive w/ Adele & Reid. 
  • Join Anne for an Exclusive Q&A. Anne is one of the investigators of Cognitive-Behavioral Conjoint Therapy for PTSD + MDMA, a Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored trial. She will be leading the MAPS funded trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA. Anne has done extensive work with communities impacted by HIV, and collaborates on projects with LGBTQ and AIDS service organizations (ASOs) on trauma-informed care and trauma treatment.  This is your chance to meet with her almost 1-1 and ask your questions regarding her studies or any of the other work she has done.  To register, see Ep 10Ex: Exclusive w/ Anne.